Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Phase 2 Study, to Evaluate Safety and Efficacy of an Acute Lymphoblastic Leukemia (ALL) Intensive Chemotherapy for Adult Lymphoblastic Lymphoma (LL).

NCT00195871 is registered in ClinicalTrials.gov with Centre Henri Becquerel as lead sponsor.

NCT NCT00195871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00195871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Phase 2 Study, to Evaluate Safety and Efficacy of an Acute Lymphoblastic Leukemia (ALL) Intensive Chemotherapy for Adult Lymphoblastic Lymphoma (LL).
Lead sponsor
Centre Henri Becquerel
Phase
Phase 2
Overall status
Unknown status
Start date
February 29, 2004
Completion date
December 31, 2015
Enrollment
155 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoblastic lymphoma